Cipla Ltd has signed agreements to acquire a 100% stake in Inzpera Healthsciences Limited, making Inzpera a wholly owned subsidiary, expected to be completed within a month. This strategic acquisition aims to enhance Cipla's pediatric pharmaceutical and wellness product offerings.